SCHEMBL20715152

SCHEMBL20715152

CC(C)S(=O)(=O)[C@H]1CCN(C)C1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20715145 0.88 SMN1; SMN2 (0.33)
SCHEMBL15837580 0.87 HTR2A (0.36) NCF1HTR2AHTR2C
SCHEMBL22245179 0.82
SCHEMBL20711788 0.79 PIK3CA (0.35)
SCHEMBL21625313 0.77 HRH3 (0.33)
SCHEMBL12324 0.76 NCF1 (0.34) NCF1HTR2AHTR2C
SCHEMBL14022395 0.76 NCF1 (0.34) NCF1HTR2AHTR2C
SCHEMBL20609823 0.74 NCF1 (0.38) NCF1
SCHEMBL17052883 0.74 NCF1 (0.38) NCF1
SCHEMBL13621103 0.74 LMNA (0.43) NCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019027960-A1 PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2019-02-07 WO disclosed